BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2014 10:47:00 AM | Browse: 946 | Download: 1233
 |
Received |
|
2014-05-15 20:18 |
|
Peer-Review Started |
|
2014-05-16 21:37 |
|
To Make the First Decision |
|
2014-06-18 17:25 |
|
Return for Revision |
|
2014-06-20 20:30 |
|
Revised |
|
2014-07-08 15:54 |
|
Second Decision |
|
2014-08-28 10:00 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2014-08-28 10:35 |
|
Articles in Press |
|
2014-08-28 10:57 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-11-16 18:19 |
|
Publish the Manuscript Online |
|
2014-12-02 10:46 |
| Category |
Oncology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Recent applications of chemosensitivity tests for colorectal cancer treatment
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yong Sik Yoon and Jin Cheon Kim |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Asan Institute for Life Sciences |
2014-69 |
| National Research Foundation |
NRF-2013R1A2A1A03070986 |
| Ministry of Science, ICT, and Future Planning, the Korea Health 21 RD Project |
HI06C0868 |
| Ministry of Science, ICT, and Future Planning, the Korea Health 21 RD Project |
HI13C1750 |
| Center for Development and Commercialization of Anti-Cancer Therapeutics |
HI10C2014 |
|
| Corresponding Author |
Jin Cheon Kim, MD, PhD, Department of Surgery, University of Ulsan College of Medicine, 88 Olympic-Ro 43-Gil, Songpa-Gu, Seoul 138-736, South Korea. jckim@amc.seoul.kr |
| Key Words |
Colorectal adenocarcinomas; Colorectal cancer; Chemotherapy; In vitro assays; Molecular targeted therapy; Individualized therapy |
| Core Tip |
This review summarizes currently available predictive and prognostic chemosensitivity tests and biomarkers in terms of cell culture, protein, and gene. Cell culture-based chemosensitivity tests are used widely in clinical practice because of their short assay period, technical simplicity, and the requirement of small amount of specimen. Among protein- and gene-based chemosensitivity assays, assessment of KRAS mutation status predicts the response to epidermal growth factor receptor-targeted therapy in colorectal cancer patients. |
| Publish Date |
2014-12-02 10:46 |
| Citation |
Yoon YS, Kim JC. Recent applications of chemosensitivity tests for colorectal cancer treatment. World J Gastroenterol 2014; 20(44): 16398-16408 |
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i44/16398.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i44.16398 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
